Search Results - "Rosenthal, DI"

Osteoid osteoma: percutaneous treatment with radiofrequency energy by Rosenthal, Daniel I, Hornicek, Francis J, Torriani, Martin, Gebhardt, Mark C, Mankin, Henry J

“…To report our experience with technical success, complications, and long-term clinical success of radiofrequency (RF) ablation of osteoid osteoma. After needle…”
Get more information

Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system by Barker, Jr, Jerry L, Garden, Adam S, Ang, K Kian, O'Daniel, Jennifer C, Wang, He, Court, Laurence E, Morrison, William H, Rosenthal, David I, Chao, K S Clifford, Tucker, Susan L, Mohan, Radhe, Dong, Lei

“…Many patients receiving fractionated radiotherapy (RT) for head-and-neck cancer have marked anatomic changes during their course of treatment, including…”
Get more information

Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy by Zhang, Lifei, Garden, Adam S, Lo, Justin, Ang, K Kian, Ahamad, Anesa, Morrison, William H, Rosenthal, David I, Chambers, Mark S, Zhu, X Ronald, Mohan, Radhe, Dong, Lei

“…To analyze three-dimensional setup uncertainties for multiple regions of interest (ROIs) in head-and-neck region. In-room computed tomography (CT) scans were…”
Get more information

Local recurrence in head and neck cancer: Relationship to radiation resistance and signal transduction by GUPTA, Anjali K, MCKENNA, W. Gillies, BERNHARD, Eric J, WEBER, Randal S, MUSCHEL, Ruth J, WEBER, Charles N, FELDMAN, Michael D, GOLDSMITH, Jeffrey D, MICK, Rosemarie, MACHTAY, Mitchell, ROSENTHAL, David I, BAKANAUSKAS, Vincent J, CERNIGLIA, George J

“…Locoregional recurrence is the dominant form of treatment failure in head and neck (H&N) cancer. The epidermal growth factor receptor (EGFR) is frequently…”
Get full text

Case 26-2016: A 28-Year-Old Woman with Back Pain and a Lesion in the Lumbar Spine by Choy, Edwin, Hornicek, Francis J, Chen, Yen-Lin, Rosenthal, Daniel I, Kerr, Darcy A

“…A 28-year-old woman presented with intractable back pain with radiation to the leg. Examination of biopsy specimens revealed a giant-cell tumor of bone…”
Get full text

Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study by Gunn, G. Brandon, Hansen, Chase C, Garden, Adam S, Fuller, Clifton D, Mohamed, Abdallah S.R, Morrison, William H, Frank, Steven J, Beadle, Beth M, Phan, Jack, Chronowski, Gregory M, Sturgis, Erich M, Lewis, Carol M, Lu, Charles, Hutcheson, Kate A, Mendoza, Tito R, Cleeland, Charles S, Rosenthal, David I

“…Abstract Background A questionnaire-based study was conducted to assess long-term patient reported outcomes (PROs) following definitive IMRT-based treatment…”
Get full text

Towards a model-based patient selection strategy for proton therapy: External validation of photon-derived Normal Tissue Complication Probability models in a head and neck proton therapy cohort by Blanchard, P, Wong, AJ, Gunn, GB, Garden, AS, Mohamed, ASR, Rosenthal, DI, Crutison, J, Wu, R, Zhang, X, Zhu, XR, Mohan, R, Amin, MV, Fuller, CD, Frank, SJ

Get full text

Sinonasal malignancies with neuroendocrine differentiation: Patterns of failure according to histologic phenotype by ROSENTHAL, David I, BARKER, Jerry L, ANG, K. Kian, CHAO, K. S, GARDEN, Adam S, EL-NAGGAR, Adel K, GLISSON, Bonnie S, KIES, Merrill S, DIAZ, Eduardo M, CLAYMAN, Gary L, DEMONTE, Franco, SELEK, Ugur, MORRISON, William H

“…Sinonasal neuroendocrine tumors are rare malignancies that are represented by a spectrum of histologies, including esthesioneuroblastoma (ENB), sinonasal…”
Get full text

Clinical outcomes and patterns of disease recurrence following intensity modulated proton therapy for oropharyngeal squamous carcinoma: results from a single institution prospective study by Gunn, GB, Blanchard, P, Garden, AS, Zhu, XR, Fuller, CD, Mohamed, ASR, Morrison, WH, Phan, J, Beadle, BM, Skinner, HD, Sturgis, EM, Kies, MS, Hutcheson, KA, Rosenthal, DI, Mohan, R, Gillin, MT, Frank, SJ

Get full text

Intensity modulated proton beam therapy (IMPT) versus Intensity modulated photon therapy (IMRT) for oropharynx cancer patients – a case matched analysis by Blanchard, P, Garden, AS, Gunn, GB, Rosenthal, DI, Morrison, WH, Hernandez, M, Crutison, J, Lee, JJ, Ye, R, Fuller, CD, Mohamed, ASR, Hutcheson, KA, Holliday, EB, Thaker, NG, Sturgis, EM, Kies, MS, Zhu, XR, Mohan, R, Frank, SJ

Get full text

Comparison of stages I–II thymoma treated by complete resection with or without adjuvant radiation by Singhal, Sunil, Shrager, Joseph B, Rosenthal, David I, LiVolsi, Virginia A, Kaiser, Larry R

“…Adjuvant radiation after resection of Masaoka stage II thymoma is widely advocated, but the evidence supporting it is controversial. Studies addressing this…”
Get full text

Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas by DeLaney, Thomas F, Spiro, Ira J, Suit, Herman D, Gebhardt, Mark C, Hornicek, Francis J, Mankin, Henry J, Rosenberg, Andrew L, Rosenthal, Daniel I, Miryousefi, Fariba, Ancukiewicz, Marcus, Harmon, David C

“…Treatment of extremity soft-tissue sarcomas yields excellent local control, but distant failure is common with large, high-grade tumors. A regimen of…”
Get more information

Differential Methylation status of tumor-associated genes in head and neck squamous carcinoma: Incidence and potential implications by MARUYA, Shin-Ichiro, ISSA, Jean-Pierre J, WEBER, Randal S, ROSENTHAL, David I, HAVILAND, Joie C, LOTAN, Reuben, EL-NAGGAR, Adel K

“…Promoter hypermethylation is one of the major mechanisms in the transcriptional inactivation of certain carcinoma-associated genes. Concurrent methylation…”
Get full text

Organ Preservation Therapy Using Induction Plus Concurrent Chemoradiation for Advanced Resectable Oropharyngeal Carcinoma: A University of Pennsylvania Phase II Trial by MACHTAY, Mitchell, ROSENTHAL, David I, HERSHOCK, Diane, JONES, Heather, WILLIAMSON, Shirnett, GREENBERG, Michael J, WEINSTEIN, Gregory S, AVILES, Victor M, CHALIAN, Ara A, WEBER, Randal S

“…To determine the efficacy, feasibility, and toxicity of a new regimen for locally advanced oropharyngeal carcinoma. Patients had technically resectable stage…”
Get full text

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism by KATZNELSON, L, FINKELSTEIN, J. S, SCHOENFELD, D. A, ROSENTHAL, D. I, ANDERSON, E. J, KLIBANSKI, A

“…Acquired hypogonadism is being increasingly recognized in adult men. However, the effects of long term testosterone replacement on bone density and body…”
Get full text

Parathyroid carcinoma: A 22-year experience by Busaidy, Naifa L., Jimenez, Camilo, Habra, Mouhammed Amir, Schultz, Pamela N., El-Naggar, Adel K., Clayman, Gary L., Asper, Joshua A., Diaz Jr, Eduardo M., Evans, Douglas B., Gagel, Robert F., Garden, Adam, Hoff, Ana O., Lee, Jeffrey E., Morrison, William H., Rosenthal, David I., Sherman, Steven I., Sturgis, Erich M., Waguespack, Steven G., Weber, Randal S., Wirfel, Kelly, Vassilopoulou-Sellin, Rena

“…Purpose. Because parathyroid carcinoma is rare, clear consensus is not available regarding the optimal management of patients with this condition. Treatment…”
Get full text

Percutaneous Radiofrequency Coagulation of Osteoid Osteoma Compared with Operative Treatment by ROSENTHAL, DANIEL I, HORNICEK, FRANCIS J, WOLFE, MICHAEL W, JENNINGS, L CANDACE, GEBHARDT, MARK C, MANKIN, HENRY J

“…Osteoid osteoma, a benign bone tumor, has traditionally been treated with operative excision. A recently developed method for percutaneous ablation of the…”
Get full text

Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck by Hustinx, R, Smith, R J, Benard, F, Rosenthal, D I, Machtay, M, Farber, L A, Alavi, A

“…Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) studies imaging FDG PET imaging is used to detect and stage head and neck cancers…”
Get full text

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy by Trotti, Andy, Garden, Adam, Warde, Padraig, Symonds, Paul, Langer, Corey, Redman, Rebecca, Pajak, Thomas F, Fleming, Tomas R, Henke, Michael, Bourhis, Jean, Rosenthal, David I, Junor, Elizabeth, Cmelak, Anthony, Sheehan, Finbarr, Pulliam, Janis, Devitt-Risse, Patricia, Fuchs, Henry, Chambers, Mark, O'Sullivan, Brian, Ang, K Kian

“…Oral mucositis (OM) causes significant morbidity during the course of radiotherapy (RT) treatment of head-and-neck cancer. It is hypothesized that infection…”
Get more information

Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck by Rosenthal, David I., Liu, Li, Lee, Jason H., Vapiwala, Neha, Chalian, Ara A., Weinstein, Gregory S., Chilian, Irina, Weber, Randal S., Machtay, Mitchell

“…Background To determine the effect of treatment time‐related factors on outcome in patients treated with surgery and postoperative radiation therapy (RT) for…”
Get full text